Back to Louisiana

HB1236 • 2026

INSURANCE: Provides relative to pharmacy benefit managers reimbursements (EN +$2,265,844 SG EX See Note)

INSURANCE: Provides relative to pharmacy benefit managers reimbursements (EN +$2,265,844 SG EX See Note)

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Jason Dewitt
Last action
2026-06-12
Official status
Signed by the Governor - Act 913
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

INSURANCE: Provides relative to pharmacy benefit managers reimbursements (EN +$2,265,844 SG EX See Note)

INSURANCE: Provides relative to pharmacy benefit managers reimbursements (EN +$2,265,844 SG EX See Note)

What This Bill Does

  • INSURANCE: Provides relative to pharmacy benefit managers reimbursements (EN +$2,265,844 SG EX See Note)

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

Plain English: SSHB1236 4878 5919 HOUSE SUMMARY OF SENATE AMENDMENTS HB 1236 2026 Regular Session Dewitt INSURANCE: Provides relative to pharmacy benefit managers reimbursements Synopsis of Senate Amendments 1.

  • SSHB1236 4878 5919 HOUSE SUMMARY OF SENATE AMENDMENTS HB 1236 2026 Regular Session Dewitt INSURANCE: Provides relative to pharmacy benefit managers reimbursements Synopsis of Senate Amendments 1.
  • Deletes provisions of proposed law relative to the authorization of copay assistance benefit plans.
  • 2.
  • Makes technical changes.

Plain English: HFAHB1236 4878 4171 FOR OFFICE USE ONLY HOUSE FLOOR AMENDMENTS 2026 Regular Session Amendments proposed by Representative Dewitt to Engrossed House Bill No.

  • HFAHB1236 4878 4171 FOR OFFICE USE ONLY HOUSE FLOOR AMENDMENTS 2026 Regular Session Amendments proposed by Representative Dewitt to Engrossed House Bill No.
  • 1236 by Representative Dewitt 1 AMENDMENT NO.
  • 1 2 On page 1, delete line 2 in its entirety and insert in lieu thereof the following: 3 "To amend and reenact R.S.
  • 22:1868(B)(introductory paragraph), (1),(2), and (4), and 4 (C), to" 5 AMENDMENT NO.

Plain English: 2026 Regular Session Sequence: 1491 HBS AMENDED BY SENATE TO BE CONCURRED IN HB 1236 BY DEWITT REJECT SENATE AMENDMENTS Date: 5/26/2026 Time: 2:20:55 PM ROLL CALL The roll was called with the following result: YEAS Adams Amedee Bacala Bamburg Bayham Beaullieu Berault Billings Boudreaux Bourriaque Boyd Boyer Brass Braud Broussard Bryant Butler Carlson Carpenter Carrier Carter, R.

  • 2026 Regular Session Sequence: 1491 HBS AMENDED BY SENATE TO BE CONCURRED IN HB 1236 BY DEWITT REJECT SENATE AMENDMENTS Date: 5/26/2026 Time: 2:20:55 PM ROLL CALL The roll was called with the following result: YEAS Adams Amedee Bacala Bamburg Bayham Beaullieu Berault Billings Boudreaux Bourriaque Boyd Boyer Brass Braud Broussard Bryant Butler Carlson Carpenter Carrier Carter, R.
  • Carter, W.
  • Carver Chassion Chenevert Coates Cox Crews Deshotel Dewitt Dickerson Domangue Echols Edmonston Egan Farnum Firment Fisher Fontenot Freeman Freiberg Gadberry Geymann Glorioso Green Hebert Henry, C.
  • Henry, D.

Plain English: SCAHB1236 3275 3319 SENATE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by Senate Committee on Insurance to Reengrossed House Bill No.

  • SCAHB1236 3275 3319 SENATE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by Senate Committee on Insurance to Reengrossed House Bill No.
  • 1236 by Representative Dewitt 1 AMENDMENT NO.
  • 1 2 On page 1, line 2, after "(1)," delete the remainder of the line and insert "and (4) and (C)(1), 3 (2), and (3)(c) and (d)," 4 AMENDMENT NO.
  • 2 5 On page 1, line 3, after "(E)," delete "and 1868.2," 6 AMENDMENT NO.

Plain English: SCAHB1236 2270 3217 SENATE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by Senate Committee on Insurance to Reengrossed House Bill No.

  • SCAHB1236 2270 3217 SENATE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by Senate Committee on Insurance to Reengrossed House Bill No.
  • 1236 by Representative Dewitt 1 AMENDMENT NO.
  • 1 2 On page 1, line 2, after "(1)," delete the remainder of the line and insert "and (4) and (C)(1), 3 (2), and (3)(c) and (d)," 4 AMENDMENT NO.
  • 2 5 On page 1, line 4, after "22:1868(B)(2)" delete "and (C)(2)" 6 AMENDMENT NO.

Bill History

  1. 2026-06-12 H

    Effective date: 06/12/2026.

  2. 2026-06-12 H

    Signed by the Governor. Becomes Act No. 913.

  3. 2026-06-04 H

    Sent to the Governor for executive approval.

  4. 2026-06-01 S

    Signed by the President of the Senate.

  5. 2026-06-01 H

    Enrolled and signed by the Speaker of the House.

  6. 2026-05-31 H

    Notice of Senate adoption of Conference Committee Report.

  7. 2026-05-31 S

    Conference Committee Report read; adopted by a vote of 35 yeas and 0 nays.

  8. 2026-05-31 S

    Notice House adopted the Conference Committee Report.

  9. 2026-05-31 H

    Conference Committee Report read, roll called, yeas 93, nays 0. The Conference Committee Report was adopted.

  10. 2026-05-29 H

    Scheduled for floor debate on 05/31/2026.

  11. 2026-05-29 H

    Conference Committee report received. Lies over under the rules.

  12. 2026-05-29 S

    Conference committee report received.

  13. 2026-05-27 S

    Notice House Conference Committee members appointed.

  14. 2026-05-27 H

    House conferees appointed: Dewitt, Firment, and Miller.

  15. 2026-05-26 H

    Notice of Senate conferees appointed.

  16. 2026-05-26 S

    Senate conference committee members appointed: Talbot, Bass, and Harris.

  17. 2026-05-26 S

    Notice House rejected the Senate amendments.

  18. 2026-05-26 H

    Read by title, roll called, yeas 99, nays 0, Senate amendments rejected, conference committee appointment pending.

  19. 2026-05-25 H

    Scheduled for concurrence on 05/26/2026.

  20. 2026-05-20 H

    Received from the Senate with amendments.

  21. 2026-05-19 S

    Rules suspended. Read by title, passed by a vote of 34 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.

  22. 2026-05-13 S

    Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.

  23. 2026-05-12 S

    Read by title and referred to the Legislative Bureau.

  24. 2026-05-11 S

    Reported favorably.

  25. 2026-05-07 S

    Read by title. Recommitted to the Committee on Finance.

  26. 2026-05-07 S

    Senate Committee amendments read and adopted.

  27. 2026-05-06 S

    Reported with amendments.

  28. 2026-04-27 S

    Read second time by title and referred to the Committee on Insurance.

  29. 2026-04-22 S

    Received in the Senate. Read first time by title and placed on the Calendar for a second reading.

  30. 2026-04-21 H

    Read third time by title, amended, roll called on final passage, yeas 102, nays 0. Finally passed, title adopted, ordered to the Senate.

  31. 2026-04-21 H

    Called from the calendar.

  32. 2026-04-20 H

    Scheduled for floor debate on 04/21/2026.

  33. 2026-04-20 H

    Notice given.

  34. 2026-04-15 H

    Read by title, returned to the calendar.

  35. 2026-04-14 H

    Scheduled for floor debate on 04/15/2026.

  36. 2026-04-13 H

    Read by title, ordered engrossed, passed to 3rd reading.

  37. 2026-04-09 H

    Read by title, substitute title adopted, lies over in the same order of business, substitute for HB No. 866 reported by the Committee on Insurance (12-0).

Official Summary Text

INSURANCE: Provides relative to pharmacy benefit managers reimbursements (EN +$2,265,844 SG EX See Note)

Current Bill Text

Read the full stored bill text
ENROLLED
ACT No. 9132026 Regular Session
HOUSE BILL NO. 1236 (Substitute for House Bill No. 866 by Representative Dewitt)
BY REPRESENTATIVES DEWITT AND ECHOLS
1 AN ACT
2 To amend and reenact R.S. 22:1868(B)(introductory paragraph), (1), and (4) and (C)(1), (2),
3 and (3)(c) and (d), to enact R.S. 22:1868(B)(5), (D), and (E), and to repeal R.S.
4 22:1868(B)(2), relative to pharmacy benefit managers; to provide for definitions; to
5 provide for pharmacy reimbursements; to prohibit certain reimbursement cost
6 assignments; to provide for certain prohibitions; to provide for an effective date; to
7 provide for retroactive application; and to provide for related matters.
8 Be it enacted by the Legislature of Louisiana:
9 Section 1. R.S. 22:1868(B)(introductory paragraph), (1), and (4) and (C)(1), (2), and
10 (3)(c) and (d) are hereby amended and reenacted and R.S. 22:1868(B)(5), (D), and (E) are
11 hereby enacted to read as follows:
12 §1868. Local pharmacy reimbursement; National Average Drug Acquisition Costs;
13 appeals
14 * * *
15 B. For purposes of this Section, the following definitions shall apply:
16 (1)(a) "Acquisition cost" means the set of National Average Drug
17 Acquisition Costs, "NADAC", as calculated by the Centers for Medicare and
18 Medicaid Services and reflected in the most recently released public file. means the
19 amount a local pharmacy actually pays to purchase a prescription drug or device, as
20 evidenced by a wholesaler or manufacturer invoice, and shall not be less than the
21 National Average Drug Acquisition Cost or NADAC published by the Centers for
22 Medicare and Medicaid Services on the date the prescription drug is dispensed.
23 (b) For drugs for which no NADAC rate is published, acquisition cost means
24 the local pharmacy's documented invoice cost or, if no invoice is available, the
25 wholesale acquisition cost as published in a nationally recognized drug pricing
26 compendium on the date of dispensing.
Page 1 of 4
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
HB NO. 1236 ENROLLED
1 (c) "Acquisition cost" is not defined by or determined at the sole discretion
2 of a pharmacy benefit manager or third-party administrator.
3 * * *
4 (4) "Reimbursement formula" means a prescription drug reimbursement
5 calculation involving an ingredient price, calculated based on a prescription drug
6 pricing benchmark plus an adjustment factor, and a professional dispensing fee.
7 (5) "Professional dispensing fee" means a fee that meets all of the following:
8 (a) Incurred at the point of sale or service and pays for costs in excess of the
9 ingredient cost of a covered outpatient drug each time a covered outpatient drug is
10 dispensed.
11 (b) Includes only pharmacy costs associated with ensuring that possession
12 of the appropriate covered outpatient drug is transferred to a beneficiary. Pharmacy
13 costs include but are not limited to reasonable costs associated with a pharmacist's
14 time in checking the computer for information about an individual's coverage,
15 performing drug utilization review and preferred drug list review activities,
16 measurement or mixing of the covered outpatient drug, filling the container,
17 beneficiary counseling, and physically providing the completed prescription to the
18 beneficiary, delivery, special packaging, and overhead associated with maintaining
19 the facility and equipment necessary to operate the pharmacy.
20 (c) Does not include administrative costs incurred by the state in the
21 operation of the covered outpatient drug benefit including systems costs for
22 interfacing with pharmacies.
23 C. Notwithstanding any provision of law to the contrary, effective January
24 1, 2026, a pharmacy benefit manager shall meet all of the following requirements for
25 claims submitted by any local pharmacy to a pharmacy benefit manager
26 administering claims on behalf of a health plan, except for the Office of Group
27 Benefits:
28 (1) Adopt a reimbursement formula using either NADAC as the prescription
29 drug pricing benchmark or, if NADAC is not available, the wholesale acquisition
30 cost. or, with prior written approval by the commissioner, an alternative prescription
Page 2 of 4
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
HB NO. 1236 ENROLLED
1 drug pricing benchmark that results in claim payment errors that are both comparable
2 to or less than NADAC in terms of frequency and smaller than NADAC in terms of
3 magnitude.
4 (2)(a) Adopt a reimbursement formula using an adjustment factor that, based
5 on claims experience data available to the pharmacy benefit manager, is reasonably
6 expected to result in a claim payment error rate of no more than two percent per drug
7 as identified by its national drug code. a professional dispensing fee that is an
8 amount not less than the professional dispensing fee established by the Louisiana
9 Department of Health for the Louisiana Medicaid program.
10 (b) The professional dispensing fee shall reflect the actual costs of the
11 professional services provided by the pharmacists and expenses related to the
12 physical act of dispensing.
13 (3) Adopt an appeal process for pharmacists to challenge claim payment
14 errors that, at a minimum, meets all of the following requirements:
15 * * *
16 (c) If an appeal is filed with the pharmacy benefit manager, the pharmacy
17 must shall include a written invoice from the wholesaler that includes the drug name,
18 national drug code number, purchase date, and cost of the drug.
19 (d) If a claim payment error occurred, the pharmacy benefit manager shall
20 make an additional payment to the pharmacy to increase the reimbursement amount
21 to the acquisition cost. The pharmacy benefit manager is prohibited from amending
22 or changing the amount a prescription drug consumer must pay for an out-of-pocket
23 cost share or expense.
24 * * *
25 D. The reimbursement formula adopted by a pharmacy benefit manager
26 pursuant to this Section shall include the professional dispensing fee required by this
27 Section as a non-recoverable cost. The pharmacy benefit manager shall not collect,
28 recoup, or recover the professional dispensing fee from any pharmacy, pharmacist,
29 or member.
Page 3 of 4
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
HB NO. 1236 ENROLLED
1 E. The commissioner may require submission of claims-level data, including
2 but not limited to reimbursement amounts, dispensing fees, and any adjustments for
3 the purpose of verifying compliance with this Section.
4 Section 2. R.S. 22:1868(B)(2) is hereby repealed in its entirety.
5 Section 3. The provisions of this Act shall be given prospective and retroactive
6 application. The provisions of Subsection D shall be applied retroactively to January 1, 2026.
7 A pharmacy benefit manager shall be deemed compliant with this retroactive application
8 upon demonstration that it has adopted and reprocessed all applicable claims retroactively
9 to January 1, 2026, using a reimbursement formula which includes the prescription drug
10 pricing benchmark described in R.S. 22:1868(C)(1) as amended herein plus a professional
11 dispensing fee that is an amount no less than nine dollars. The reimbursement formula shall
12 also apply prospectively and the deemed compliance applicable to the retroactive application
13 shall not be construed to apply to the prospective application of this Act. All other
14 provisions of this Act shall apply prospectively only.
15 Section 4. This Act shall become effective upon signature by the governor or, if not
16 signed by the governor, upon expiration of the time for bills to become law without signature
17 by the governor, as provided by Article III, Section 18 of the Constitution of Louisiana. If
18 vetoed by the governor and subsequently approved by the legislature, this Act shall become
19 effective on the day following such approval.
SPEAKER OF THE HOUSE OF REPRESENTATIVES
PRESIDENT OF THE SENATE
GOVERNOR OF THE STATE OF LOUISIANA
APPROVED:
Page 4 of 4
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.